In addition to the noted effects of hormone receptors on the oncogenic signaling pathway in tumor development and progression, emerging data suggest that these receptors can also modulate effects on tumor metabolism and metabolic reprogramming in HR+ breast cancer [19,20,21,59]. Here, NR4A1 is linked to breast cancer.